Tissue sampling in lung cancer: A review in light of the MERIT experienceRECK, Martin; HERMES, Andreas; TAN, Eng-Huat et al.Lung cancer. 2011, Vol 74, Num 1, pp 1-6, issn 0169-5002, 6 p.Article

Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinomaPOON, Donald; CHOWBAY, Balram; CHEUNG, Yin-Bun et al.Cancer. 2005, Vol 103, Num 3, pp 576-581, issn 0008-543X, 6 p.Article

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancerQINGYU ZHOU; SPARREBOOM, Alex; TAN, Eng-Huat et al.British journal of clinical pharmacology. 2005, Vol 59, Num 4, pp 415-424, issn 0306-5251, 10 p.Article

The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer. A retrospective analysisTOH, Chee-Keong; WONG, Ee-Hwee; LIM, Wan-Teck et al.Chest. 2004, Vol 126, Num 6, pp 1750-1756, issn 0012-3692, 7 p.Article

Primary intrathoracic malignant effusion: A descriptive studyANG, Peter; TAN, Eng-Huat; LEONG, Swan-Swan et al.Chest. 2001, Vol 120, Num 1, pp 50-54, issn 0012-3692Article

Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXR∝ and HNF4∝) on docetaxel disposition in Chinese nasopharyngeal cancer patientsCHEW, Sin-Chi; LIM, Joanne; SINGH, Onkar et al.European journal of clinical pharmacology. 2014, Vol 70, Num 2, pp 155-166, issn 0031-6970, 12 p.Article

Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinomaWONG, Zee-Wan; TAN, Eng-Huat; YAP, Swee-Peng et al.Head & neck. 2002, Vol 24, Num 6, pp 549-554, issn 1043-3074Article

Erlotinib in previously treated non-small-cell lung cancerSHEPHERD, Frances A; PEREIRA, José Rodrigues; VAN KOOTEN, Maximiliano et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 123-132, issn 0028-4793, 10 p.Article

Never-smokers with lung cancer : Epidemiologic evidence of a distinct disease entityTOH, Chee-Keong; FEI GAO; TAN, Eng-Huat et al.Journal of clinical oncology. 2006, Vol 24, Num 15, pp 2245-2251, issn 0732-183X, 7 p.Article

The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsCHEW, Sin-Chi; SINGH, Onkar; XIANGAI CHEN et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1471-1478, issn 0344-5704, 8 p.Article

Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokersTOH, Chee-Keong; FEI GAO; TAN, Eng-Huat et al.Lung cancer. 2007, Vol 56, Num 2, pp 161-166, issn 0169-5002, 6 p.Article

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinomaPOON, Donald; YAP, Swee-Peng; WONG, Zee-Wan et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 5, pp 1312-1318, issn 0360-3016, 7 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal CarcinomaLIM, Wan-Teck; NG, Quan-Sing; TONG SAN KOH et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5481-5489, issn 1078-0432, 9 p.Article